Cambrex Corp. | Ownership
Companies that own Cambrex Corp.
BlackRock Fund Advisors
4,352,068
13.09%
415,772
0.02%
06/30/2018
The Vanguard Group, Inc.
3,131,831
9.42%
74,689
0.01%
06/30/2018
William Blair Investment Management LLC
2,302,338
6.92%
331,005
0.42%
06/30/2018
Dimensional Fund Advisors LP
1,420,580
4.26%
13,858
0.02%
06/30/2018
Jackson Square Partners LLC
1,264,303
3.8%
341,639
0.31%
06/30/2018
ClearBridge Investments LLC
1,157,166
3.48%
178,817
0.07%
06/30/2018
Mackenzie Financial Corp.
1,037,025
3.12%
303,196
0.12%
06/30/2018
SSgA Funds Management, Inc.
905,306
2.72%
81,252
0.01%
06/30/2018
BNY Mellon Asset Management North America Corp.
824,504
2.48%
42,738
0.03%
06/30/2018
American Capital Management, Inc.
720,476
2.17%
45,312
2.16%
06/30/2018
| Address |
One Meadowlands Plaza
East Rutherford New Jersey 07073
United States
|
|
Employees
|
- |
| Website |
http://www.cambrex.com |
| Updated |
07/08/2019 |
| Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. |
